: Leading medical experts, policymakers, and researchers convened at the All India Institute of Medical Sciences (AIIMS) Guwahati for a two-day National Conclave and Policy Dialogue on Tuberculosis, held from October 30–31, 2025, to chart a roadmap for genomic testing-based TB elimination in India.

Organized under the theme “Upgrading and Upscaling Universal Drug Susceptibility Testing (UDST) for Tuberculosis and Transitioning from Phenotypic Testing to Genomic Testing: TB Mortality Reduction and Disease Elimination for Viksit Bharat 2047,” the conclave emphasized innovation, precision diagnostics, and policy coordination in advancing India’s fight against tuberculosis.

The event brought together clinicians, molecular biologists, microbiologists, policymakers, and TB survivors, underscor

See Full Page